View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsGABY 과거 순이익 실적과거 기준 점검 0/6GABY 의 수입은 연평균 -26.4%의 비율로 감소해 온 반면, Pharmaceuticals 산업은 연평균 19.2%의 비율로 증가했습니다. 매출은 연평균 51%의 비율로 증가해 왔습니다.핵심 정보-26.43%순이익 성장률27.86%주당순이익(EPS) 성장률Pharmaceuticals 산업 성장률23.06%매출 성장률50.98%자기자본이익률n/a순이익률-154.72%최근 순이익 업데이트31 Mar 2023최근 과거 실적 업데이트Reported Earnings • Jun 02First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$4.74m (down 18% from 1Q 2022). Net loss: US$1.56m (down 224% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.Reported Earnings • May 03Full year 2022 earnings released: US$0.04 loss per share (vs US$0.018 loss in FY 2021)Full year 2022 results: US$0.04 loss per share (further deteriorated from US$0.018 loss in FY 2021). Revenue: US$21.8m (down 15% from FY 2021). Net loss: US$29.3m (loss widened 202% from FY 2021). Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.005 loss per share (vs US$0.005 loss in 3Q 2021)Third quarter 2022 results: US$0.005 loss per share (in line with 3Q 2021). Revenue: US$5.35m (down 29% from 3Q 2021). Net loss: US$3.76m (loss widened 10% from 3Q 2021).Reported Earnings • Aug 30Second quarter 2022 earnings released: US$0.004 loss per share (vs US$0.002 loss in 2Q 2021)Second quarter 2022 results: US$0.004 loss per share (down from US$0.002 loss in 2Q 2021). Revenue: US$5.18m (down 44% from 2Q 2021). Net loss: US$3.04m (loss widened 136% from 2Q 2021).Reported Earnings • May 31First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: CA$7.33m (up 115% from 1Q 2021). Net income: CA$1.55m (up CA$4.07m from 1Q 2021). Profit margin: 21% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.Reported Earnings • May 01Full year 2021 earnings released: CA$0.023 loss per share (vs CA$0.056 loss in FY 2020)Full year 2021 results: CA$0.023 loss per share (up from CA$0.056 loss in FY 2020). Revenue: CA$32.4m (up CA$28.4m from FY 2020). Net loss: CA$12.2m (loss narrowed 4.5% from FY 2020). Over the next year, revenue is forecast to grow 26%, compared to a 14% growth forecast for the industry in Canada. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.모든 업데이트 보기Recent updates공시 • Aug 18+ 1 more updateGABY Inc. Announces Executive ResignationsGABY Inc. announced that it is immediately winding down operations which is expected to be concluded by August 31, 2023. The Board of Directors and the sole remaining officers of the Company, Simon Lileikis, Interim CEO and President and Leanne Likness, Corporate Secretary have resigned their respective offices effective immediately.Reported Earnings • Jun 02First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$4.74m (down 18% from 1Q 2022). Net loss: US$1.56m (down 224% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.공시 • May 04Ggaby Inc. Announces CEO ChangesGABY Inc. announced that Margot Micallef, the Company's Founder and Chief Executive Officer ("CEO"), will take a temporary leave of absence from her role as CEO of the Company. Ms. Micallef is temporarily resigning her position as CEO for personal reasons but will continue to represent the Company as its Chair and serve on the board of directors of GABY (the "Board"). The Board has appointed Simon Lileikis, GABY's current President, to serve as the Company's Interim CEO. Mr. Lileikis was appointed President of GABY in 2021.Reported Earnings • May 03Full year 2022 earnings released: US$0.04 loss per share (vs US$0.018 loss in FY 2021)Full year 2022 results: US$0.04 loss per share (further deteriorated from US$0.018 loss in FY 2021). Revenue: US$21.8m (down 15% from FY 2021). Net loss: US$29.3m (loss widened 202% from FY 2021). Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.분석 기사 • Feb 11Health Check: How Prudently Does GABY (CSE:GABY) Use Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.005 loss per share (vs US$0.005 loss in 3Q 2021)Third quarter 2022 results: US$0.005 loss per share (in line with 3Q 2021). Revenue: US$5.35m (down 29% from 3Q 2021). Net loss: US$3.76m (loss widened 10% from 3Q 2021).Reported Earnings • Aug 30Second quarter 2022 earnings released: US$0.004 loss per share (vs US$0.002 loss in 2Q 2021)Second quarter 2022 results: US$0.004 loss per share (down from US$0.002 loss in 2Q 2021). Revenue: US$5.18m (down 44% from 2Q 2021). Net loss: US$3.04m (loss widened 136% from 2Q 2021).공시 • Jul 19Gaby Inc. Announces Changes to its Board of DirectorsGABY Inc. announce that Glenn Solomon QC has been appointed to the Board of Directors, effective July 14, 2022. Mr. Solomon replaces Mr. Loreto Grimaldi who stepped down from the Board effective, July 13, 2022. Mr. Solomon is a Calgary lawyer and businessperson. He has a BA (University of Calgary), a law degree (University of Alberta) and two Masters of Law Degrees (Osgoode Hall Law School, York University, Toronto), as well as a "Director" designation from the Institute of Corporate Directors (ICD.D). Mr. Solomon is a Fellow of the Chartered Institute of Arbitrators (UK) and a Fellow of Litigation Counsel of America which is limited to one-half of one percent of lawyers. In 2010, Mr. Solomon was awarded a Queen's Counsel designation by the Lieutenant Governor on behalf of the Queen in Right of Alberta, an honor bestowed on only the highest-ranking lawyers. He has also been honoured as a recipient of the Alberta Centennial Medal in recognition of his significant contributions to his fellow citizens, his community and Alberta, and was honoured as a recipient of the Queen Elizabeth II Diamond Jubilee Medal in 2012 in recognition of his significant contribution to his countrymen and his community. Mr. Solomon has had an AV Preeminent peer review rating continuously since 2012, and an AV Preeminent judicial review rating continuously since 2015, in legal ability and ethical standards from LexisNexis Martindale-Hubbell and Lawyers.com - the higher rating given. He has also been consistently recognized as a peer-reviewed leading practitioner by Best Lawyers in Canada in Corporate and Commercial Litigation since 2015, and in Privacy and Data Security since 2021. In 2022, Best Lawyers in Canada recognized Mr. Solomon as the "Lawyer of the Year" in Privacy and Data Security in Calgary. He has been recognized as a "Litigation Star" by Benchmark Litigation since 2012, in the areas of Administrative Law, Arbitration, Commercial Litigation, Energy Litigation and Insurance Litigation. Since 2014, Mr. Solomon has been recognized as a distinguished practitioner in Dispute Resolution by Chambers Global, the internationally renowned legal directory. Mr. Solomon has been recognized among Litigation and Product Liability Lawyers by Legal Media Group Guides to the Litigation Lawyers, Expert Guides (2014 - 2016), as a "Top Rated Lawyer in Canada" by Corporate Counsel Magazine (2013 - 2014), The American Lawyer Magazine (2013 - 2014), and American Lawyer Media (2013 - 2014).Reported Earnings • May 31First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: CA$7.33m (up 115% from 1Q 2021). Net income: CA$1.55m (up CA$4.07m from 1Q 2021). Profit margin: 21% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.Reported Earnings • May 01Full year 2021 earnings released: CA$0.023 loss per share (vs CA$0.056 loss in FY 2020)Full year 2021 results: CA$0.023 loss per share (up from CA$0.056 loss in FY 2020). Revenue: CA$32.4m (up CA$28.4m from FY 2020). Net loss: CA$12.2m (loss narrowed 4.5% from FY 2020). Over the next year, revenue is forecast to grow 26%, compared to a 14% growth forecast for the industry in Canada. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.공시 • Mar 04+ 1 more updateGaby Inc. Appoints Paul Stacey to the Role of Senior Vice-President FinanceGABY Inc. announced the appointment of Paul Stacey to the role of Senior Vice-President Finance effective immediately. Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys - a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds. As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PricewaterhouseCoopers.Board Change • Dec 31High number of new directorsIndependent Director Loreto Grimaldi was the last director to join the board, commencing their role in 2021.Reported Earnings • Nov 26Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.006 loss per share (vs CA$0.006 loss in 3Q 2020). Revenue: CA$9.53m (up CA$8.72m from 3Q 2020). Net loss: CA$4.29m (loss widened 209% from 3Q 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 57% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 01Second quarter 2021 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: CA$11.3m (up CA$10.5m from 2Q 2020). Net loss: CA$1.58m (loss narrowed 6.6% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 57% per year, which means it is significantly lagging earnings.공시 • Jun 18GABY Inc. Announces State-Wide Launch of New Lifestyle Cannabis Brand, Kind RepublicGABY Inc. announced the statewide launch of Kind Republic™, a California based lifestyle cannabis brand. Formerly an exclusive brand to Mankind Dispensary, it is set to launch state-wide on June 28, 2021. Manufactured and distributed by GABY owned Sonoma Pacific Distribution Inc. ("Sonoma Pacific"), Kind RepublicTM products will soon be available in dispensaries across the State of California. Kind RepublicTM caters to Californian's outdoor lifestyle culture, launching with a selection of prerolls, concentrates, and flower, cultivated and crafted in California keeping with the dispensary's high-quality roster of cannabis products. The new offerings will be promoted across the state and will also remain available to purchase in-store and online, through Mankind Dispensary.Reported Earnings • May 13Full year 2020 earnings releasedThe company reported a soft full year result with weaker revenues and control over costs, although losses reduced. Full year 2020 results: Revenue: CA$4.07m (down 63% from FY 2019). Net loss: CA$12.8m (loss narrowed 44% from FY 2019).공시 • Feb 05GABY Inc. announced that it has received CAD 8.646456 million in fundingOn February 4, 2021, GABY Inc. (CNSX:GABY) closed the transaction. The company issued 172,929,123 subscription receipts for gross proceeds of CAD 8,646,456.15.공시 • Jan 23GABY Inc., Annual General Meeting, Mar 25, 2021GABY Inc., Annual General Meeting, Mar 25, 2021.공시 • Jan 09GABY Inc. to Appoint Javier Estades to its Board of DirectorsGABY Inc. will appoint Javier Estades to its board of directors. As President and CEO of Tabacalera USA Inc., Javier's expertise in branding, customer experience, retail strategy, and online sales, will be invaluable to the future of GABY.공시 • Dec 04+ 1 more updateGABY Inc. announced that it expects to receive CAD 11 million in fundingGABY Inc. (CNSX:GABY) announced that it has entered into an agreement for a brokered best efforts private placement of 220,000,000 subscription receipts at a price of CAD 0.05 per subscription receipt for gross proceeds of CAD 11,000,000 on December 3, 2020. Each subscription receipt will entitle the holder to purchase units of the company. Each unit will consist of one common share and one share purchase warrant. Each warrant will entitle the holder to purchase a common share at a price of CAD 0.09 per share for a period of 24 months from issuance, provided that if, at any time prior to the expiry date of the Warrants, the volume weighted average trading price of the common shares on the CSE, or other principal exchange on which the company's shares are listed, is greater than C$0.18 for 5 consecutive trading days. The company has granted the agents option to offer up to additional 15% of the number of subscription receipts sold at any time up to 48 hours prior to the closing. The transaction is expected to close on or about the week of December 21, 2020.분석 기사 • Dec 02Are Insiders Buying GABY Inc. (CSE:GABY) Stock?It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...매출 및 비용 세부 내역GABY가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이CNSX:GABY 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비31 Mar 2321-3210031 Dec 2222-2910030 Sep 2221-810030 Jun 2224-811031 Mar 2229-611031 Dec 2126-1010030 Sep 2120-128030 Jun 2113-107031 Mar 215-105031 Dec 203-106030 Sep 204-147030 Jun 207-148031 Mar 208-159031 Dec 198-159030 Sep 196-88030 Jun 192-87031 Mar 191-65031 Dec 181-64030 Sep 181-53030 Jun 181-43031 Mar 181-32031 Dec 171-32031 Dec 160-22031 Dec 150-220양질의 수익: GABY 은(는) 현재 수익성이 없습니다.이익 마진 증가: GABY는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: GABY은 수익성이 없으며 지난 5년 동안 손실이 연평균 26.4% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 GABY의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: GABY은 수익성이 없어 지난 해 수익 성장률을 Pharmaceuticals 업계(96.7%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: GABY의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2023/12/04 13:43종가2023/09/06 00:00수익2023/03/31연간 수익2022/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스GABY Inc.는 1명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Joseph GomesNOBLE Capital Markets, Inc.
Reported Earnings • Jun 02First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$4.74m (down 18% from 1Q 2022). Net loss: US$1.56m (down 224% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.
Reported Earnings • May 03Full year 2022 earnings released: US$0.04 loss per share (vs US$0.018 loss in FY 2021)Full year 2022 results: US$0.04 loss per share (further deteriorated from US$0.018 loss in FY 2021). Revenue: US$21.8m (down 15% from FY 2021). Net loss: US$29.3m (loss widened 202% from FY 2021). Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.
Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.005 loss per share (vs US$0.005 loss in 3Q 2021)Third quarter 2022 results: US$0.005 loss per share (in line with 3Q 2021). Revenue: US$5.35m (down 29% from 3Q 2021). Net loss: US$3.76m (loss widened 10% from 3Q 2021).
Reported Earnings • Aug 30Second quarter 2022 earnings released: US$0.004 loss per share (vs US$0.002 loss in 2Q 2021)Second quarter 2022 results: US$0.004 loss per share (down from US$0.002 loss in 2Q 2021). Revenue: US$5.18m (down 44% from 2Q 2021). Net loss: US$3.04m (loss widened 136% from 2Q 2021).
Reported Earnings • May 31First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: CA$7.33m (up 115% from 1Q 2021). Net income: CA$1.55m (up CA$4.07m from 1Q 2021). Profit margin: 21% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.
Reported Earnings • May 01Full year 2021 earnings released: CA$0.023 loss per share (vs CA$0.056 loss in FY 2020)Full year 2021 results: CA$0.023 loss per share (up from CA$0.056 loss in FY 2020). Revenue: CA$32.4m (up CA$28.4m from FY 2020). Net loss: CA$12.2m (loss narrowed 4.5% from FY 2020). Over the next year, revenue is forecast to grow 26%, compared to a 14% growth forecast for the industry in Canada. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.
공시 • Aug 18+ 1 more updateGABY Inc. Announces Executive ResignationsGABY Inc. announced that it is immediately winding down operations which is expected to be concluded by August 31, 2023. The Board of Directors and the sole remaining officers of the Company, Simon Lileikis, Interim CEO and President and Leanne Likness, Corporate Secretary have resigned their respective offices effective immediately.
Reported Earnings • Jun 02First quarter 2023 earnings releasedFirst quarter 2023 results: Revenue: US$4.74m (down 18% from 1Q 2022). Net loss: US$1.56m (down 224% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.
공시 • May 04Ggaby Inc. Announces CEO ChangesGABY Inc. announced that Margot Micallef, the Company's Founder and Chief Executive Officer ("CEO"), will take a temporary leave of absence from her role as CEO of the Company. Ms. Micallef is temporarily resigning her position as CEO for personal reasons but will continue to represent the Company as its Chair and serve on the board of directors of GABY (the "Board"). The Board has appointed Simon Lileikis, GABY's current President, to serve as the Company's Interim CEO. Mr. Lileikis was appointed President of GABY in 2021.
Reported Earnings • May 03Full year 2022 earnings released: US$0.04 loss per share (vs US$0.018 loss in FY 2021)Full year 2022 results: US$0.04 loss per share (further deteriorated from US$0.018 loss in FY 2021). Revenue: US$21.8m (down 15% from FY 2021). Net loss: US$29.3m (loss widened 202% from FY 2021). Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.
분석 기사 • Feb 11Health Check: How Prudently Does GABY (CSE:GABY) Use Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Dec 01Third quarter 2022 earnings released: US$0.005 loss per share (vs US$0.005 loss in 3Q 2021)Third quarter 2022 results: US$0.005 loss per share (in line with 3Q 2021). Revenue: US$5.35m (down 29% from 3Q 2021). Net loss: US$3.76m (loss widened 10% from 3Q 2021).
Reported Earnings • Aug 30Second quarter 2022 earnings released: US$0.004 loss per share (vs US$0.002 loss in 2Q 2021)Second quarter 2022 results: US$0.004 loss per share (down from US$0.002 loss in 2Q 2021). Revenue: US$5.18m (down 44% from 2Q 2021). Net loss: US$3.04m (loss widened 136% from 2Q 2021).
공시 • Jul 19Gaby Inc. Announces Changes to its Board of DirectorsGABY Inc. announce that Glenn Solomon QC has been appointed to the Board of Directors, effective July 14, 2022. Mr. Solomon replaces Mr. Loreto Grimaldi who stepped down from the Board effective, July 13, 2022. Mr. Solomon is a Calgary lawyer and businessperson. He has a BA (University of Calgary), a law degree (University of Alberta) and two Masters of Law Degrees (Osgoode Hall Law School, York University, Toronto), as well as a "Director" designation from the Institute of Corporate Directors (ICD.D). Mr. Solomon is a Fellow of the Chartered Institute of Arbitrators (UK) and a Fellow of Litigation Counsel of America which is limited to one-half of one percent of lawyers. In 2010, Mr. Solomon was awarded a Queen's Counsel designation by the Lieutenant Governor on behalf of the Queen in Right of Alberta, an honor bestowed on only the highest-ranking lawyers. He has also been honoured as a recipient of the Alberta Centennial Medal in recognition of his significant contributions to his fellow citizens, his community and Alberta, and was honoured as a recipient of the Queen Elizabeth II Diamond Jubilee Medal in 2012 in recognition of his significant contribution to his countrymen and his community. Mr. Solomon has had an AV Preeminent peer review rating continuously since 2012, and an AV Preeminent judicial review rating continuously since 2015, in legal ability and ethical standards from LexisNexis Martindale-Hubbell and Lawyers.com - the higher rating given. He has also been consistently recognized as a peer-reviewed leading practitioner by Best Lawyers in Canada in Corporate and Commercial Litigation since 2015, and in Privacy and Data Security since 2021. In 2022, Best Lawyers in Canada recognized Mr. Solomon as the "Lawyer of the Year" in Privacy and Data Security in Calgary. He has been recognized as a "Litigation Star" by Benchmark Litigation since 2012, in the areas of Administrative Law, Arbitration, Commercial Litigation, Energy Litigation and Insurance Litigation. Since 2014, Mr. Solomon has been recognized as a distinguished practitioner in Dispute Resolution by Chambers Global, the internationally renowned legal directory. Mr. Solomon has been recognized among Litigation and Product Liability Lawyers by Legal Media Group Guides to the Litigation Lawyers, Expert Guides (2014 - 2016), as a "Top Rated Lawyer in Canada" by Corporate Counsel Magazine (2013 - 2014), The American Lawyer Magazine (2013 - 2014), and American Lawyer Media (2013 - 2014).
Reported Earnings • May 31First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: CA$7.33m (up 115% from 1Q 2021). Net income: CA$1.55m (up CA$4.07m from 1Q 2021). Profit margin: 21% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has fallen by 62% per year, which means it is significantly lagging earnings.
Reported Earnings • May 01Full year 2021 earnings released: CA$0.023 loss per share (vs CA$0.056 loss in FY 2020)Full year 2021 results: CA$0.023 loss per share (up from CA$0.056 loss in FY 2020). Revenue: CA$32.4m (up CA$28.4m from FY 2020). Net loss: CA$12.2m (loss narrowed 4.5% from FY 2020). Over the next year, revenue is forecast to grow 26%, compared to a 14% growth forecast for the industry in Canada. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.
공시 • Mar 04+ 1 more updateGaby Inc. Appoints Paul Stacey to the Role of Senior Vice-President FinanceGABY Inc. announced the appointment of Paul Stacey to the role of Senior Vice-President Finance effective immediately. Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys - a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds. As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PricewaterhouseCoopers.
Board Change • Dec 31High number of new directorsIndependent Director Loreto Grimaldi was the last director to join the board, commencing their role in 2021.
Reported Earnings • Nov 26Third quarter 2021 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2021 results: CA$0.006 loss per share (vs CA$0.006 loss in 3Q 2020). Revenue: CA$9.53m (up CA$8.72m from 3Q 2020). Net loss: CA$4.29m (loss widened 209% from 3Q 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 57% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 01Second quarter 2021 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: CA$11.3m (up CA$10.5m from 2Q 2020). Net loss: CA$1.58m (loss narrowed 6.6% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 57% per year, which means it is significantly lagging earnings.
공시 • Jun 18GABY Inc. Announces State-Wide Launch of New Lifestyle Cannabis Brand, Kind RepublicGABY Inc. announced the statewide launch of Kind Republic™, a California based lifestyle cannabis brand. Formerly an exclusive brand to Mankind Dispensary, it is set to launch state-wide on June 28, 2021. Manufactured and distributed by GABY owned Sonoma Pacific Distribution Inc. ("Sonoma Pacific"), Kind RepublicTM products will soon be available in dispensaries across the State of California. Kind RepublicTM caters to Californian's outdoor lifestyle culture, launching with a selection of prerolls, concentrates, and flower, cultivated and crafted in California keeping with the dispensary's high-quality roster of cannabis products. The new offerings will be promoted across the state and will also remain available to purchase in-store and online, through Mankind Dispensary.
Reported Earnings • May 13Full year 2020 earnings releasedThe company reported a soft full year result with weaker revenues and control over costs, although losses reduced. Full year 2020 results: Revenue: CA$4.07m (down 63% from FY 2019). Net loss: CA$12.8m (loss narrowed 44% from FY 2019).
공시 • Feb 05GABY Inc. announced that it has received CAD 8.646456 million in fundingOn February 4, 2021, GABY Inc. (CNSX:GABY) closed the transaction. The company issued 172,929,123 subscription receipts for gross proceeds of CAD 8,646,456.15.
공시 • Jan 23GABY Inc., Annual General Meeting, Mar 25, 2021GABY Inc., Annual General Meeting, Mar 25, 2021.
공시 • Jan 09GABY Inc. to Appoint Javier Estades to its Board of DirectorsGABY Inc. will appoint Javier Estades to its board of directors. As President and CEO of Tabacalera USA Inc., Javier's expertise in branding, customer experience, retail strategy, and online sales, will be invaluable to the future of GABY.
공시 • Dec 04+ 1 more updateGABY Inc. announced that it expects to receive CAD 11 million in fundingGABY Inc. (CNSX:GABY) announced that it has entered into an agreement for a brokered best efforts private placement of 220,000,000 subscription receipts at a price of CAD 0.05 per subscription receipt for gross proceeds of CAD 11,000,000 on December 3, 2020. Each subscription receipt will entitle the holder to purchase units of the company. Each unit will consist of one common share and one share purchase warrant. Each warrant will entitle the holder to purchase a common share at a price of CAD 0.09 per share for a period of 24 months from issuance, provided that if, at any time prior to the expiry date of the Warrants, the volume weighted average trading price of the common shares on the CSE, or other principal exchange on which the company's shares are listed, is greater than C$0.18 for 5 consecutive trading days. The company has granted the agents option to offer up to additional 15% of the number of subscription receipts sold at any time up to 48 hours prior to the closing. The transaction is expected to close on or about the week of December 21, 2020.
분석 기사 • Dec 02Are Insiders Buying GABY Inc. (CSE:GABY) Stock?It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...